The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
The Joint Corp.NASDAQ: JYNT
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue growth accelerates
Q1 FY2026 cost of revenue of $3.12M rose 5.0% year over year, ahead of the -3.3% change in trailing-twelve-month cost of revenue. Sequentially, it rose 10.6% from the prior quarter. Over 3 fiscal years it compounded at +7.0% a year.
Context
- Cost of revenue amounted to 20.4% of revenue in FY2025, down 1.6 pp from a year earlier.
- Cost of revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +5.0% holds above the trailing-twelve-month pace of -3.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 11.23M USD
- Year-over-year change
- -2.5%
- 4-year CAGR
- +10.0%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.23M | -2.5% |
| FY2024 | 2024-12-31 | 11.52M | +9.9% |
| FY2023 | 2023-12-31 | 10.48M | +14.3% |
| FY2022 | 2022-12-31 | 9.17M | +19.6% |
| FY2021 | 2021-12-31 | 7.67M | — |
Cost of Revenue vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's LTM Mar 2026 cost of revenue of $11.37M is the 6th highest of the 11 companies compared; the peer median is $18.65M.
- Its year-over-year change of -3.3% is the 8th highest of 10, against a peer median of +8.2%.
- Cost of revenue amounts to 20.1% of revenue for JYNT, versus a peer median of 79.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $212.57M | -38.1% | -7.9% | 70.5% | |
| LTM Mar 2026 | $84.84M | +38.8% | -8.6% | 68.3% | |
| LTM Mar 2026 | $59.36M | +2.0% | +2.1% | 31.5% | |
| LTM Mar 2026 | $37.86M | +65.4% | +30.0% | 67.7% | |
| LTM Mar 2026 | $30.12M | +8.2% | +0.4% | 87.6% | |
| LTM Mar 2026 | $11.37M | -3.3% | +7.0% | 20.1% | |
| LTM Mar 2026 | $7.19M | +2.8% | +27.8% | 140.0% | |
| LTM Mar 2026 | $820.02K | +29.4% | -1.9% | 206.6% | |
| LTM Mar 2026 | $166K | +58.1% | -5.3% | 291.2% | |
| LTM Mar 2026 | $129K | — | — | — | |
| LTM Mar 2026 | $0 | -100.0% | — | — | |
| Peer median (excluding JYNT) | $18.65M | +8.2% | -0.8% | 79.0% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 80.01M | 101.25M | 46.98M | 52.16M | 54.9M |
| Cost of Revenue | 7.67M | 9.17M | 10.48M | 11.52M | 11.23M |
| Gross Profit | 72.35M | 92.08M | 36.5M | 40.65M | 43.67M |
| Gross Margin | 90.4% | 90.9% | 77.7% | 77.9% | 79.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 62.27M | 81.95M | 34.92M | 41.1M | 42.93M |
| Operating Expenses | 66.22M | 91.25M | 36.18M | 42.54M | 44.58M |
| Depreciation & Amortization | 3.92M | 6.65M | 8.58M | 4.72M | 1.71M |
| EBITDA | 10.07M | 7.89M | 8.88M | 2.9M | 1.48M |
| EBITDA Margin | 12.6% | 7.8% | 18.9% | 5.6% | 2.7% |
| Operating Income | 6.13M | 828.25K | 318.3K | (1.89M) | (905.48K) |
| Operating Margin | 7.7% | 0.8% | 0.7% | -3.6% | -1.6% |
| Interest Income | 0 | 133.1K | 0 | 280.29K | 0 |
| Interest Expense | 0 | 953.53K | 64.29K | 0 | 0 |
| Other Income / Expenses | (69.88K) | (133.1K) | (64.29K) | 280.29K | 675.97K |
| Income Before Tax | 6.06M | 695.15K | 254.01K | (1.61M) | (229.5K) |
| Pre-Tax Margin | 7.6% | 0.7% | 0.5% | -3.1% | -0.4% |
| Income Tax Expense | (1.51M) | 68.45K | 11.02M | 5.61K | 38.65K |
| Net Income | 7.57M | 626.71K | (9.75M) | (5.8M) | 2.91M |
| Net Margin | 9.5% | 0.6% | -20.8% | -11.1% | 5.3% |
| EPS (Basic) | 0.46 | 0.04 | (0.66) | (0.39) | 0.19 |
| EPS (Diluted) | 0.44 | 0.04 | (0.66) | (0.39) | 0.19 |
| Weighted Avg Shares | 14.32M | 14.49M | 14.69M | 14.92M | 15.13M |
| Weighted Avg Shares (Diluted) | 14.94M | 14.87M | 14.69M | 15.15M | 15.13M |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.